KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angio... KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. Show more
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted fifty-two newly-hired employees inducement options to...
–Orphan drug designation paves the way for potential of sebetralstat to be first oral on-demand treatment for HAE in Japan– – Submission advances Company’s strategic plan to address unmet needs...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) today announced that the compensation committee of KalVista’s board of directors granted nine newly-hired employees inducement options to purchase an...
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that Jeb Ledell has joined the Company as Chief Operating Officer (COO). Mr. Ledell is an accomplished public company COO with a...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.9 | 10.1809954751 | 8.84 | 9.94 | 8.52 | 335897 | 9.14176924 | CS |
4 | 1.015 | 11.6332378223 | 8.725 | 9.94 | 7.3 | 320093 | 8.51092353 | CS |
12 | -0.88 | -8.28625235405 | 10.62 | 10.97 | 7.3 | 373187 | 9.00077881 | CS |
26 | -2.4 | -19.7693574959 | 12.14 | 13.5225 | 7.3 | 356872 | 10.39730153 | CS |
52 | -5.46 | -35.9210526316 | 15.2 | 16.8793 | 7.3 | 455067 | 12.04797318 | CS |
156 | -3.35 | -25.5920550038 | 13.09 | 17.345 | 4.12 | 349903 | 10.58997208 | CS |
260 | -6.65 | -40.5735204393 | 16.39 | 45 | 4.12 | 319674 | 15.58015398 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales